Acadia Pharmaceuticals buy Mizuho
Start price
28.02.24
/
50%
€21.60
Target price
28.02.25
€36.02
Performance (%)
-34.93%
Price
13.06.24
€14.06
Summary
This prediction is currently active. Massive losses of -34.93% have been the result for the BUY prediction by Mizuho. This prediction currently runs until 28.02.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 0.214% | 0.214% |
iShares Core DAX® | -1.816% | -2.419% |
iShares Nasdaq 100 | 4.333% | 8.073% |
iShares Nikkei 225® | 0.657% | 1.234% |
iShares S&P 500 | 2.968% | 4.613% |
Comments by Mizuho for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Mizuho from $40.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Mizuho for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.12.23
29.12.23
€36.19
29.12.24
29.12.24
-50.51%
13.06.24
13.06.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.40
06.11.23
06.11.23
€32.59
06.11.24
06.11.24
-37.25%
13.06.24
13.06.24